Center of Excellence for Cardiovascular Safety Research and Mechanistic Pharmacology, Johnson & Johnson Pharmaceutical Research and Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium.
Br J Pharmacol. 2010 Dec;161(7):1444-54. doi: 10.1111/j.1476-5381.2010.00934.x.
In cardiovascular pharmacology, electrical and mechanical events can be distinguished, and the phrase 'electro-mechanical window' (EMw) describes the temporal difference between these events. We studied whether changes in EMw have potential predictive value for the occurrence of arrhythmias in fentanyl/etomidate-anaesthetized beagle (FEAB) dogs.
The EMw was calculated as differences between the QT interval and QLVP(end) in FEAB dogs during atrial pacing, treatment with isoprenaline or atropine, body temperature changes and induction of Torsade de Pointes (TdP) in an LQT1 model.
The electrical systole (QT interval) was shorter than the duration of the mechanical event (QLVP(end) ), providing a positive EMw. Atrial pacing, atropine or body temperature changes had no major effects on EMw, despite large changes in QT duration. However, β-adrenoceptor stimulation (with isoprenaline) decreased the EMw (from 90 to 5 ms) and in combination with HMR1556, a blocker of the slowly activating potassium current (I(Ks) ), induced a large negative EMw (-109ms) and TdP. Prevention of TdP by atenolol or verapamil was associated with a less negative EMw (-23 to -16ms). Mexiletine, a poorly effective long QT treatment, did not affect the EMw or prevent TdP induction.
The EMw is a marker, other than QT prolongation, of TdP risk in the FEAB model. Therefore, we suggest examining the EMw as a risk marker in cardiovascular safety studies and as a potential biomarker to improve clinical management of long QT syndrome patients, especially in patients with borderline QT prolongation.
在心血管药理学中,可以区分电和机械事件,“电-机械窗(EMw)”一词描述了这些事件之间的时间差异。我们研究了 fentanyl/etomidate 麻醉的比格犬(FEAB)中 EMw 的变化是否对心律失常的发生具有潜在的预测价值。
在 FEAB 犬心房起搏、异丙肾上腺素或阿托品治疗、体温变化和 LQT1 模型中诱发尖端扭转型室性心动过速(TdP)期间,通过计算 QT 间期和 QLVP(end)之间的差异来计算 EMw。
电收缩(QT 间期)短于机械事件(QLVP(end))的持续时间,提供了一个正的 EMw。尽管 QT 间期有很大变化,但心房起搏、阿托品或体温变化对 EMw 没有重大影响。然而,β-肾上腺素能受体刺激(异丙肾上腺素)降低了 EMw(从 90 至 5 ms),并且与 HMR1556 联合使用,一种缓慢激活钾电流(I(Ks))的阻滞剂,诱导了一个大的负 EMw(-109 ms)和 TdP。用阿替洛尔或维拉帕米预防 TdP 与负 EMw 减少有关(-23 至-16 ms)。米力农,一种治疗长 QT 效果不佳的药物,不会影响 EMw 或预防 TdP 的诱导。
EMw 是 FEAB 模型中 TdP 风险的除 QT 延长以外的标志物。因此,我们建议在心血管安全性研究中检查 EMw 作为风险标志物,并作为改善长 QT 综合征患者临床管理的潜在生物标志物,特别是在具有临界 QT 延长的患者中。